Horizon Therapeutics plc Reports Strong Third-Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Horizon Pharma (HZNP) Tops Q3 EPS by 15c, Offers Guidance
November 6, 2019 7:16 AM ESTHorizon Pharma (NASDAQ: HZNP) reported Q3 EPS of $0.64, $0.15 better than the analyst estimate of $0.49. Revenue for the quarter came in at $665.5 million versus the consensus estimate of $329.76 million.
GUIDANCE:
Horizon Pharma sees Q4 2019 revenue of $1.28-1.3 billion, versus the consensus of... More
